Integral Diagnostics Stock

Integral Diagnostics Dividend

The Dividend of Integral Diagnostics (IDX.AX) as of Jul 22, 2026 is 0.09 AUD. In the previous year, Dividend was 0.08 AUD — a change of 12.07% (higher).

Dividend

0.09AUD

YoY

12.07%

Dividend yield

4.46 %

Last updated:

How much dividend does Integral Diagnostics 2026 pay?

According to the latest status from July 2026, Integral Diagnostics paid a total of 0.09 AUD per share in dividends within the last 12 months. With the current Integral Diagnostics price of 2.08 AUD, this corresponds to a dividend yield of 3.98 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 4.46%. The payout ratio is around 615% of earnings. The dividend has grown at 5.5% per year over the past 9 years.

Historical Integral Diagnostics Dividends

A dividend is paid times per year. Last year, the payout months were April and September.

PaydateDividend
9/29/20250.06AUD
4/6/20250.04AUD
9/30/20240.05AUD
3/29/20240.04AUD
10/1/20230.05AUD
4/2/20230.04AUD
10/1/20220.04AUD
4/1/20220.06AUD
10/2/20210.10AUD
4/1/20210.08AUD
9/28/20200.06AUD
3/28/20200.08AUD
9/30/20190.07AUD
4/1/20190.07AUD
10/1/20180.06AUD
3/3/20180.06AUD
10/1/20170.06AUD
3/28/20170.04AUD
10/1/20160.06AUD

Integral Diagnostics dividend history and estimates

In 2025, Integral Diagnostics paid a dividend amounting to 0.09 AUD. Dividend means that Integral Diagnostics distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.18 AUD
0.00 AUD
Jan 1, 2022
0.10 AUD
0.00 AUD
Jan 1, 2023
0.09 AUD
0.00 AUD
Jan 1, 2024
0.08 AUD
0.00 AUD
Jan 1, 2025
0.09 AUD
0.00 AUD
Jan 1, 2026 (e)
0.06 AUD
0.06 AUD
Jan 1, 2027 (e)
0.00 AUD
0.11 AUD
Jan 1, 2028 (e)
0.00 AUD
0.11 AUD

Is the Integral Diagnostics Dividend Safe?

Integral Diagnostics has been increasing the dividend for 1 years.

Over a five-year period, the distribution dropped by -7.31%.

Analysts expect a Dividend Increase of 10.94% for the current fiscal year.

Integral Diagnostics dividend payout ratio

In 2025, Integral Diagnostics had a payout ratio of 614.95%. The payout ratio indicates the percentage of the company's profits that Integral Diagnostics distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
114.49 %
Jan 1, 2022
145.14 %
Jan 1, 2023
80.71 %
Jan 1, 2024
-31.87 %
Jan 1, 2025
614.95 %
Jan 1, 2026 (e)
89.75 %
Jan 1, 2027 (e)
75.01 %
Jan 1, 2028 (e)
63.25 %

Dividend Details

Understanding Integral Diagnostics's Dividend Distributions

Integral Diagnostics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Integral Diagnostics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Integral Diagnostics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Integral Diagnostics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Integral Diagnostics Stock analysis

What does Integral Diagnostics do? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Integral Diagnostics stock

Over the past 12 months, Integral Diagnostics paid a dividend of 0.09 AUD . This corresponds to a dividend yield of about 4.46 %. For the coming 12 months, Integral Diagnostics is expected to pay a dividend of 0.11 AUD.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Integral Diagnostics